Lecture 3: G-Protein Coupled Receptors (GPCRs)


Introduction to G-Protein Coupled Receptors (GPCRs)

  • Clinical Significance:

    • GPCRs are the largest class of drug targets, accounting for roughly 30% of all drugs currently on the market. Drugs act as either agonists (activating) or antagonists (inhibiting).

GPCR Structure and Signal Initiation

  • Structural Composition:

    • Transmembrane Domains: 7 trans-membrane alpha helical domains (multi-pass proteins).

    • Cytosolic and Extracellular Domains: 4 domains located on each side of the cell

  • Ligand Binding and Activation:

    • GPCRs interact with a wide range of ligands including hormones (Glucagon, Epinephrine, Vasopressin, Serotonin, TSH), metabolites, and light.

    • Specific residues on the internal (hydrophobic) surface of the transmembrane alpha helices form a highly specific interaction surface for ligands.

    • The GEF Role: Upon ligation, the receptor undergoes structural changes that convert the inactive receptor into a Guanine-nucleotide Exchange Factor (GEF). This allows the receptor to interact with the trimeric G-protein complex.

Signal Relay by Trimeric G-Proteins

  • Mechanism of the Molecular Switch:

    • G-proteins exist in an "off" state when bound to Guanosine diphosphate (GDP).

    • They switch to an "on" state by exchanging GDP for Guanosine triphosphate (GTP).

    • The signal is turned off when the G-protein hydrolyses GTP back into GDP and inorganic phosphate.

  • The Trimeric Complex Components:

    • The complex consists of three subunits: α\alpha, β\beta, and γ\gamma.

    • The GαG_{\alpha} subunit is the primary component that binds GTP or GDP.

    • At the "Resting State," the trimeric αβγ\alpha \beta \gamma complex is bound together with GDP in the GαG_{\alpha} subunit.

  • Step-by-Step Activation:

    1. Ligand Binding: Hormone binds to the GPCR, inducing a conformational change in C3 and C4 that forms docking site for G protein.

    2. Receptor-G Protein Interaction: The active receptor docks with the G-trimer.

    3. Nucleotide Exchange: The receptor acts as a GEF, changing the shape of GαG_{\alpha}, which decreases its affinity for GDP and increases its affinity for GTP.

    4. Dissociation: The binding of GTP triggers the dissociation of GαG_{\alpha} from both the receptor and the GβγG_{\beta \gamma} complex.

    5. Effector Activation: The dissociated Gα-GTPG_{\alpha}\text{-GTP} (and sometimes the GβγG_{\beta \gamma} complex) binds to and activates an effector protein.

    6. Deactivation: The hormone dissociates from the receptor. The signalling concludes when GαG_{\alpha} hydrolyses GTP to GDP, causing it to dissociate from the effector and re-associate with GβγG_{\beta \gamma}.

G-Protein Diversity and Effector Pathways

  • The specific type of GαG_{\alpha} subunit dictates which effector pathway is activated.

  • Humans possess 21 different GαG_{\alpha} subunits, 6 different GβG_{\beta} subunits, and 12 different GγG_{\gamma} subunits.

  • Effectros usually activated by GαG_{\alpha} protein

The Adenylate Cyclase and PKA Pathway

  • Adenylate (Adenylyl) Cyclase (AC):

    • GCPR use AC as effector, cAMP as second messenger.

    • Structure: A multi-pass transmembrane protein with two cytosolic catalytic domains.

    • Activation (GαsG_{\alpha s}): Induces a conformational change that brings the two catalytic domains together to form an active site.

    • Inhibition (GαiG_{\alpha i}): Induces a conformational change that forces catalytic domains apart.

    • Reaction: AC catalyses the conversion of ATP to cyclic AMP (cAMP) by cleaving the γ\gamma and β\beta phosphates.

  • Protein Kinase A (PKA):

    • Inactive State: Consists of 4 subunits: 2 catalytic subunits inhibited by 2 regulatory subunits.

    • Activation: cAMP binds to the regulatory subunits, inducing a conformational change that releases the catalytic subunits.

    • Function: PKA is a Serine/Threonine kinase that phosphorylates various target proteins to trigger cellular responses.

  • PKA can trigger biological response by converting glycogen ←→ glucose via phosphorylation

The Phospholipase C (PLC) and Calcium Pathway

  • Mechanism:

    • GPCRs interacting with GαqG_{\alpha q} or GαoG_{\alpha o} activate Phospholipase C (lipid cutter), a plasma membrane-bound enzyme.

    • PLC hydrolyses the phosphoester bond in the phospholipid (PIP2PIP_2).

  • Cleavage Products (Second Messengers):

    • Inositol-1,4,5-bis-phosphate (IP3IP_3): It binds to and opens IP3-gatedIP_3\text{-gated} calcium channels, flooding the cytosol with Ca2+Ca^{2+}.

    • Diacylglycerol (DAG): Remains anchored in the plasma membrane.

  • Protein Kinase C (PKC) Activation:

    • Inactive PKC binds to cytosolic Ca2+Ca^{2+}, causing it to relocalise to the plasma membrane.

    • Once at the membrane, it binds to DAG, becoming fully active.

    • Active PKC phosphorylates target proteins like transcription factors and enzymes.

Calcium Signalling

  • Homeostasis: Cytosolic Ca2+Ca^{2+} concentrations are maintained at very low levels in resting cells.

  • Ca2+ Sensing Proteins:

    • EF Hand Motifs: Found in proteins like Calmodulin.

    • C2 Domains: Found in Protein Kinase C.

  • Calmodulin Effects:

    • Calcium-bound calmodulin activates several enzymes, including:

      • Ca2+/calmodulin-dependentCa^{2+}/calmodulin\text{-dependent} kinase (CAM Kinase): General phosphorylation of multiple targets.

      • Myosin light chain kinase: Regulates smooth muscle contraction.

      • Glycogen Synthase Kinase: Inhibits glycogen synthesis.

Mechanisms for Turning Signaling Off

  • 1. Turning off the GPCR:

    • Active GPCRs are phosphorylated on the 3rd intracellular loop and C-terminal tail by GPCR kinases (GRKs).

    • Phosphorylation prevents further G-protein recruitment and allows Arrestin proteins to bind.

    • Arrestins direct the receptor for internalisation (endocytosis). The receptor is then either dephosphorylated and recycled to the membrane or sent for degradation.

  • 2. Turning off G-proteins:

    • The interaction between an active GαG_{\alpha} and its effector protein increases the intrinsic GTPase activity of the GαG_{\alpha} subunit.

    • GTP is hydrolysed to GDP, returning the trimeric G-protein to its inactive "off" state.

  • 3. Turning off Second Messengers:

    • cAMP: Cleaved by cAMP Phosphodiesterase, which breaks the cyclic ring to produce 5'-AMP (which cannot signal).

    • IP3IP_3: Dephosphorylated by phosphatases to become inert.

Revision Tips: The A's and C's

  • Adenylate Cyclase pathway (Follow the A's): Adenylate cyclase →\rightarrow cAMP →\rightarrow Protein Kinase A (PKA).

  • Phospholipase C pathway (Follow the C's): Phospholipase C →\rightarrow Protein Kinase C (PKC) →\rightarrow Calcium →\rightarrow Calmodulin.